A female infant is born prematurely at 28 weeks' gestation. Shortly after birth, she shows signs of dyspnea, cyanosis, and tachypnea. She is placed on a ventilator for assisted breathing, and a diagnosis of neonatal respiratory distress syndrome (hyaline membrane disease) is made. Which of the following is the cause of this syndrome?
Which of the following can cause hyperbilirubinemia in a child?
What is the most common cause of low birth weight babies?
Which bedside monitoring tool is commonly used for neonates with hypoxic-ischemic encephalopathy (HIE)?
In a neonate with asymptomatic hypoglycemia, immediate treatment should include which of the following?
A newborn baby presented with profuse bleeding from the umbilical stump. The rest of the examination and PT, APTT are within normal limits. What is the most probable diagnosis?
According to the Sarnat staging of hypoxic-ischemic encephalopathy (HIE), in which stage are neonatal seizures most commonly seen?
Kernicterus is associated with which of the following?
All the following are true about transient tachypnea of the newborn except?
Cerebral blood flow in an asphyxiated child is best measured by:
Explanation: **Explanation:** **Correct Answer: C. Lack of fetal pulmonary maturity and deficiency of surfactant** Neonatal Respiratory Distress Syndrome (NRDS), or Hyaline Membrane Disease, is primarily caused by a **deficiency of pulmonary surfactant** in premature lungs. Surfactant, produced by **Type II pneumocytes**, begins significant production around 24–28 weeks of gestation but reaches mature levels only after 34–35 weeks. Surfactant reduces alveolar surface tension; its absence leads to widespread alveolar collapse (atelectasis), decreased lung compliance, and impaired gas exchange, resulting in the classic clinical triad of tachypnea, cyanosis, and grunting. **Analysis of Incorrect Options:** * **A. Bronchopulmonary Dysplasia (BPD):** This is a *chronic* lung disease and a potential **complication** of NRDS and long-term mechanical ventilation, not the cause. * **B. Intraventricular Hemorrhage (IVH):** This is a common **complication** of prematurity due to the fragility of the germinal matrix, often exacerbated by the hypoxia and blood pressure fluctuations seen in NRDS. * **D. Necrotizing Enterocolitis (NEC):** This is a gastrointestinal emergency of prematurity characterized by intestinal ischemia and necrosis; it is not the etiology of respiratory distress. **High-Yield Clinical Pearls for NEET-PG:** * **L/S Ratio:** A Lecithin-to-Sphingomyelin ratio **>2:1** in amniotic fluid indicates fetal lung maturity. * **Chest X-ray Findings:** Characterized by a diffuse **"ground-glass" appearance** and prominent **air bronchograms**. * **Risk Factors:** Prematurity (most common), maternal diabetes, and Cesarean section without labor. * **Prevention:** Antenatal corticosteroids (e.g., Betamethasone) administered to the mother to accelerate fetal lung maturation. * **Treatment:** Early CPAP and exogenous surfactant replacement therapy (e.g., Poractant alfa).
Explanation: **Explanation:** **Correct Answer: A. Breast milk jaundice** **Mechanism:** Breast milk jaundice is a common cause of unconjugated hyperbilirubinemia in neonates. It typically occurs after the first week of life (peaking at 2 weeks). The underlying pathophysiology involves substances in breast milk, such as **beta-glucuronidase** and non-esterified fatty acids, which inhibit the enzyme **UDP-glucuronosyltransferase (UGT1A1)** and increase the enterohepatic circulation of bilirubin. **Why the other options are incorrect:** * **B. Cystic Fibrosis:** While CF can cause hepatobiliary issues (like neonatal cholestasis or biliary cirrhosis) in older children due to inspissated bile, it is not a primary or common cause of neonatal hyperbilirubinemia compared to breast milk jaundice. * **C. Fanconi’s Syndrome:** This is a generalized proximal renal tubular dysfunction (leading to loss of glucose, amino acids, and phosphates in urine). It does not involve bilirubin metabolism or the hepatobiliary system. (Note: Do not confuse this with *Fanconi Anemia*, which is a DNA repair defect). **High-Yield NEET-PG Pearls:** * **Breastfeeding Jaundice vs. Breast Milk Jaundice:** Breastfeeding jaundice occurs in the **first week** due to *inadequate* milk intake (dehydration/decreased calorie intake). Breast milk jaundice occurs **after the first week** in healthy, thriving infants. * **Management:** Continue breastfeeding. If bilirubin levels are dangerously high, brief interruption (24–48 hours) can lead to a rapid drop, but this is rarely necessary. * **Kramer’s Rule:** Used for clinical assessment of jaundice progression (Cephalo-caudal progression). * **Crigler-Najjar Syndrome:** A severe genetic deficiency of UGT1A1 causing persistent unconjugated hyperbilirubinemia.
Explanation: **Explanation:** Low Birth Weight (LBW) is defined by the WHO as a birth weight of less than **2,500 grams**, regardless of gestational age. Globally and in India, the two primary determinants of LBW are **Prematurity** (born before 37 weeks) and **Intrauterine Growth Restriction (IUGR)**. **Why Prematurity is the Correct Answer:** Prematurity is the leading cause of LBW. Since the majority of fetal weight gain occurs during the third trimester (specifically after 28 weeks), any infant born before 37 weeks has insufficient time to accumulate subcutaneous fat and muscle mass, resulting in a lower birth weight. In clinical practice, most LBW babies are premature, whereas most IUGR babies are "Small for Gestational Age" (SGA). **Analysis of Incorrect Options:** * **A. Anemia:** While maternal anemia is a significant risk factor for IUGR and preterm labor, it is a *contributory* factor rather than the direct classification or most common cause. * **B. Infection:** Maternal infections (e.g., TORCH, UTIs) can trigger preterm labor or cause fetal growth restriction, but they represent a specific etiology rather than the most frequent underlying mechanism. * **D. Diabetes:** Maternal diabetes (especially Gestational Diabetes) is typically associated with **Macrosomia** (birth weight >4000g or >90th percentile) rather than low birth weight, unless complicated by severe vasculopathy. **High-Yield Clinical Pearls for NEET-PG:** * **VLBW (Very Low Birth Weight):** <1,500 grams. * **ELBW (Extremely Low Birth Weight):** <1,000 grams. * **Ponderal Index:** Used to differentiate between Symmetrical and Asymmetrical IUGR. * **Kangaroo Mother Care (KMC):** The most effective intervention for stable LBW babies to prevent hypothermia and promote growth.
Explanation: ### Explanation **Correct Answer: A. aEEG (amplitude-integrated electroencephalography)** **Why it is correct:** In neonates with Hypoxic-Ischemic Encephalopathy (HIE), **aEEG** is the preferred bedside monitoring tool because it provides a simplified, continuous trend of brain electrical activity. It uses a limited number of electrodes to compress raw EEG data into a time-compressed display, allowing clinicians to monitor background activity, detect subclinical seizures, and assess the severity of encephalopathy in real-time. It is particularly vital for identifying candidates for **therapeutic hypothermia** and predicting long-term neurodevelopmental outcomes. **Why the other options are incorrect:** * **B. heeG:** This is a non-existent medical term. * **C. cEEG (continuous electroencephalography):** While cEEG is the "gold standard" for diagnosing seizures, it is technically demanding, requires specialized interpretation by a neurologist, and is often not available for immediate, continuous bedside use in many NICUs. aEEG is the more common "bedside" screening tool. * **D. nEEG:** This is not a standard clinical abbreviation for neonatal monitoring. **High-Yield Clinical Pearls for NEET-PG:** * **Sarnat Staging:** Clinical tool used to grade HIE (Stage I: Hyperalert; Stage II: Lethargic/Seizures; Stage III: Comatose/Flaccid). * **Therapeutic Hypothermia:** Indicated for moderate-to-severe HIE (Sarnat Stage II/III). It must be initiated within **6 hours** of birth, maintaining a core temperature of **33.5°C for 72 hours**. * **aEEG Patterns:** A "flat trace" or "burst suppression" on aEEG indicates severe brain injury and a poor prognosis. * **MRI Brain:** The imaging modality of choice for HIE, ideally performed between **3–5 days** of life (DWI sequence is most sensitive early on).
Explanation: ### Explanation The management of neonatal hypoglycemia is a high-yield topic for NEET-PG, and the distinction between **symptomatic** and **asymptomatic** cases is critical. **1. Why "None of the above" is correct:** According to the American Academy of Pediatrics (AAP) and standard protocols, the first-line management for an **asymptomatic** neonate with hypoglycemia is **enteral feeding** (breastfeeding or formula). Intravenous (IV) dextrose boluses are reserved for symptomatic neonates or those who fail to respond to enteral feeds. None of the options provided (A, B, or C) represent the standard initial management for an asymptomatic case. **2. Analysis of Incorrect Options:** * **Option A (100 mg/kg Dextrose):** This is a dosage calculation, not a standard clinical order. While 2 ml/kg of 10% Dextrose equals 200 mg/kg, "100 mg/kg" is sub-therapeutic for a bolus. * **Option B (2 mg/kg 10% Dextrose):** This is a common distractor. The correct dose for a symptomatic bolus is **2 ml/kg** of 10% Dextrose (which equals 200 mg/kg), not 2 mg/kg. * **Option C (2 ml/kg 25% Dextrose):** 25% Dextrose is **hypertonic** and contraindicated in neonates as a bolus due to the risk of rebound hypoglycemia and intracranial hemorrhage (due to rapid osmolarity changes). Only 10% Dextrose (D10W) is used for boluses in neonatology. **3. Clinical Pearls for NEET-PG:** * **Definition:** Hypoglycemia in neonates is generally defined as blood glucose **<40–45 mg/dL**. * **Symptomatic Management:** Immediate IV bolus of **2 ml/kg of 10% Dextrose**, followed by a continuous Glucose Infusion Rate (GIR) of **6–8 mg/kg/min**. * **Asymptomatic Management:** Encourage feeding and re-check glucose in 30–60 minutes. * **High-Yield Fact:** If hypoglycemia persists despite a GIR of >12 mg/kg/min, investigations for hyperinsulinism (e.g., Critical Sample) should be initiated.
Explanation: ### Explanation **Correct Answer: B. Glanzmann thrombasthenia** **Why it is correct:** Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder caused by a deficiency or dysfunction of the **GP IIb/IIIa complex**, which is essential for platelet aggregation. A classic, high-yield clinical presentation of GT is **profuse umbilical stump bleeding** in a neonate. Since GT is a disorder of platelet function (qualitative defect) and not a coagulation factor deficiency, the **PT (Prothrombin Time) and APTT (Activated Partial Thromboplastin Time) remain normal**. The platelet count is also typically normal, but the bleeding time is prolonged. **Why the other options are incorrect:** * **Factor X deficiency:** This is a coagulation factor disorder. Deficiency would result in **prolongation of both PT and APTT**, which contradicts the normal values provided in the question. * **Von Willebrand disease (vWD):** While vWD is a common bleeding disorder, it rarely presents with umbilical stump bleeding in the neonatal period. Furthermore, severe vWD often shows a **prolonged APTT** due to its role in stabilizing Factor VIII. * **Bernard-Soulier disease:** This is caused by a deficiency of **GP Ib-IX-V** (the receptor for vWF). While it presents with mucosal bleeding, it is characterized by **thrombocytopenia and giant platelets** on a peripheral smear, which distinguishes it from GT. **High-Yield Clinical Pearls for NEET-PG:** * **Glanzmann Thrombasthenia:** Normal platelet count + Normal PT/APTT + Defective platelet aggregation with ADP, Collagen, and Epinephrine + **Normal aggregation with Ristocetin**. * **Bernard-Soulier Syndrome:** Low platelet count + Giant platelets + **Defective aggregation with Ristocetin** (not corrected by adding normal plasma). * **Umbilical Stump Bleeding:** Always consider **Factor XIII deficiency** if PT/APTT are normal and the clot solubility test is abnormal. However, among the given options, GT is the most likely diagnosis for a primary platelet plug defect.
Explanation: **Explanation:** The **Sarnat and Sarnat Staging** is a clinical tool used to grade the severity of Hypoxic-Ischemic Encephalopathy (HIE) in newborns. **Why Stage II is correct:** Stage II (Moderate HIE) is characterized by **cerebral irritability**. In this stage, the neonate is lethargic or obtunded, showing increased muscle tone and brisk deep tendon reflexes. Crucially, this is the stage where **neonatal seizures are most frequent and prominent**. The EEG in Stage II typically shows a "periodic" or "burst-suppression" pattern, reflecting significant but potentially reversible cortical dysfunction. **Why other options are incorrect:** * **Stage I (Mild):** The infant is hyper-alert and jittery. Sympathetic activity is high (tachycardia, mydriasis), but **seizures are absent**, and the EEG is usually normal. * **Stage III (Severe):** The infant is in a stupor or coma. While brain injury is most severe here, the brain is often "electrically silent." Seizures are **uncommon** in this stage because the neuronal damage is so extensive that the cortex cannot generate or sustain organized seizure activity. * **Stage IV:** There is no Stage IV in the classic Sarnat classification; it consists of only three stages. **NEET-PG High-Yield Pearls:** * **Stage I:** Duration <24 hours; prognosis is excellent. * **Stage II:** Duration 2–14 days; prognosis is variable. * **Stage III:** Duration weeks; high mortality and severe long-term neurological deficits (e.g., cerebral palsy). * **Key differentiator:** If a question mentions "hyper-alert" baby, think Stage I. If "seizures" are mentioned, think Stage II. If "absent reflexes/flaccid," think Stage III.
Explanation: **Explanation:** **Kernicterus** (Chronic Bilirubin Encephalopathy) is a permanent neurological sequela caused by the deposition of **unconjugated bilirubin** in specific brain regions, most notably the **Basal Ganglia** (Globus pallidus and subthalamic nuclei), **Brainstem nuclei** (auditory and oculomotor), and the **Cerebellum**. The correct answer is **D (All of the above)** because the clinical features of Kernicterus directly reflect the damage to these specific anatomical sites: 1. **Choreoathetoid Cerebral Palsy:** Damage to the **Basal Ganglia** results in extrapyramidal movement disorders. Choreoathetosis is the hallmark motor manifestation of chronic bilirubin toxicity. 2. **Hearing Abnormalities:** Bilirubin has a high affinity for the **Auditory Nerve (CN VIII)** and the **Cochlear Nuclei** in the brainstem. This typically manifests as sensorineural hearing loss or auditory neuropathy spectrum disorder. 3. **Upward Gaze Palsy:** Involvement of the **Oculomotor nuclei** in the brainstem leads to characteristic vertical gaze abnormalities, specifically a limitation of upward gaze (Parinaud-like syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **Most common site affected:** Globus Pallidus. * **MRI Finding:** High-intensity signals in the Globus Pallidus on T2-weighted images. * **Clinical Triad:** Extrapyramidal disturbances (Athetosis), Auditory abnormalities, and Oculomotor impairment. * **Teeth:** May show enamel hypoplasia or green staining (bilirubin staining of deciduous teeth). * **Prevention:** Timely management of neonatal jaundice using the **Bhutani Nomogram** to guide phototherapy and exchange transfusion.
Explanation: **Explanation:** **Transient Tachypnea of the Newborn (TTN)**, also known as "Wet Lung Disease," is a benign, self-limiting condition. **Why Option D is the correct answer (The Exception):** TTN is characterized by its **transient** nature. By definition, it is a non-progressive condition that typically resolves within 24 to 72 hours with minimal supportive care (such as supplemental oxygen). Unlike Respiratory Distress Syndrome (RDS) or Meconium Aspiration Syndrome, TTN **does not progress to respiratory failure** or require long-term mechanical ventilation if left to its natural course. **Analysis of Incorrect Options:** * **Option A:** TTN is most **commonly seen in term** or late-preterm babies. Risk factors include elective Cesarean section (due to lack of thoracic squeeze and hormonal surges that trigger fluid resorption) and maternal diabetes. * **Option B:** The pathophysiology involves **delayed clearance of fetal lung fluid** by the pulmonary lymphatic system and delayed activation of epithelial sodium channels (ENaC). * **Option C:** Chest X-ray typically shows **hyperexpanded lung fields**, prominent vascular markings (perihilar streaking/“sunburst appearance”), and occasionally fluid in the horizontal fissure. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Early onset of tachypnea (RR >60) shortly after birth. * **Management:** Primarily supportive (Oxygen via hood or nasal cannula). * **Diagnosis of Exclusion:** It is often a diagnosis made after ruling out neonatal pneumonia or RDS. * **Key Trigger:** Elective C-section without labor is the most common predisposing factor mentioned in exams.
Explanation: **Explanation:** In the context of neonatal asphyxia (Hypoxic-Ischemic Encephalopathy), the assessment of cerebral perfusion and oxygenation requires a method that is non-invasive, continuous, and available at the bedside. **Why NIRS is the Correct Answer:** **Near-Infrared Spectroscopy (NIRS)** is the preferred clinical tool for monitoring cerebral blood flow (CBF) and oxygenation in neonates. It utilizes the ability of near-infrared light to penetrate the skull and be absorbed by hemoglobin. By measuring the ratio of oxygenated to deoxygenated hemoglobin, it provides a real-time **Regional Oxygen Saturation (rSO2)** value. This serves as a surrogate for cerebral blood flow, allowing clinicians to detect fluctuations in perfusion immediately at the bedside without transporting a critically ill, ventilated neonate. **Why Other Options are Incorrect:** * **PET (Positron Emission Tomography):** While the gold standard for measuring metabolic activity and blood flow, it involves exposure to ionizing radiation and requires transport to a specialized suite, making it impractical for an unstable asphyxiated neonate. * **Radionuclide Imaging:** Similar to PET, this involves radioactive tracers and lacks the real-time, continuous monitoring capability required in the NICU. * **MRI Angiography:** MRA provides excellent structural detail of blood vessels but does not measure dynamic, real-time blood flow or tissue oxygenation. The logistical challenge of moving a sick neonate into an MRI scanner limits its use for routine monitoring. **Clinical Pearls for NEET-PG:** * **NIRS Normal Range:** Cerebral rSO2 in neonates is typically **60–80%**. * **Autoregulation:** In asphyxiated neonates, cerebral autoregulation is often "pressure-passive," meaning CBF fluctuates directly with systemic blood pressure; NIRS is vital to monitor this. * **Other uses:** NIRS is also used to monitor renal perfusion and mesenteric oxygenation (to screen for NEC).
Neonatal Resuscitation
Practice Questions
Care of the Normal Newborn
Practice Questions
Prematurity and Low Birth Weight
Practice Questions
Respiratory Distress Syndrome
Practice Questions
Neonatal Jaundice
Practice Questions
Neonatal Sepsis
Practice Questions
Necrotizing Enterocolitis
Practice Questions
Intraventricular Hemorrhage
Practice Questions
Persistent Pulmonary Hypertension
Practice Questions
Perinatal Asphyxia
Practice Questions
Neonatal Seizures
Practice Questions
Congenital Anomalies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free